Utah Medical Products, Inc.
NASDAQ:UTMD 4:00:00 PM EDT
Earnings Announcements
UTMD Reports Audited Year 2022 And Fourth Quarter Financial Performance
Published: 01/31/2023 14:15 GMT
Utah Medical Products, Inc. (UTMD) - Utmd Reports Audited Year 2022 and Fourth Quarter Financial Performance.
Utah Medical Products Inc - Total Consolidated 4q 2022 Utmd Worldwide Sales Were $661, 5.1% Higher Than in 4q 202.
Utah Medical Products Inc - U.S. Domestic Sales Were 7% Lower and Outside U.S. Sales Were 25% Higher Than in 4q 2021.
Utah Medical Products Inc - Diluted EPS in 4q 2022 Were $1.253.
Utah Medical Products Inc - Total Consolidated 4q 2022 Utmd Worldwide Sales Were $661, 5.1% Higher Than in 4q 202.
Utah Medical Products Inc - U.S. Domestic Sales Were 7% Lower and Outside U.S. Sales Were 25% Higher Than in 4q 2021.
Utah Medical Products Inc - Diluted EPS in 4q 2022 Were $1.253.